| |
|
|
|
Oasmia Pharmaceutical AB (publ)  
|
|
1.55 0 (0%) |
08-21 15:56 |
|
Open: |
1.57 |
Pre close: |
1.55 |
Target:
|
2.15 
|
|
High: |
1.57 |
Low: |
1.55 |
Resistance:
|
1.84
2.09
|
|
Volume: |
7,769 |
Market Cap: |
131M |
Support:
|
1.44
1.20
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.55
 |
MACD |
MACD(12,26):
|
-0.07 |
|
MA(20): |
1.66 |
Signal(12,26,9): |
-0.05 |
|
MA(100): |
1.79 |
Stochastic Oscillator |
%K(14,3):
|
25.57 |
|
MA(250): |
2.66 |
%D(3): |
22.07 |
|
Average Volume(K) |
3-Month: |
24447
|
52-Week |
High:
|
5.70 |
|
10-Days: |
1181 |
Low: |
0.94 |
|
RSI |
RSI(14):
|
46.08 |
Change(%): |
-13.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.291 |
Return on Equity (ttm) |
-44.5 |
Shares Out. (M) |
83.03 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-12.4 |
Shares Float (M) |
53.45 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.14 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.079 |
Shares Short (K) |
11 |
|
Book Value (p.s.) |
0.610 |
EBITDA (p.s.) |
0.000 |
P/E |
-5.33 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.54 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
